Soleus Capital Management »

4d Molecular Therapeutics In shares owned by Soleus Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.3M 197k 31.86
2023-12-31 $927k 46k 20.26
2023-09-30 $1.6M 124k 12.73
2023-06-30 $4.0M 219k 18.07
2023-03-31 $8.1M 469k 17.19
2022-12-31 $5.7M 255k 22.21
2021-09-30 $3.3M 121k 26.97
2021-06-30 $2.4M 101k 24.08
2021-03-31 $3.7M 86k 43.38